NF‐κB inhibition triggers death of imatinib‐sensitive and imatinib‐resistant chronic myeloid leukemia cells including T315I Bcr‐Abl mutants von Lounnas, Nadia, Frelin, Catherine, Gonthier, Nadège, Colosetti, Pascal, Sirvent, Anne, Cassuto, Jil‐Patrice, Berthier, Fréderic, Sirvent, Nicolas, Rousselot, Philippe, Dreano, Michel, Peyron, Jean‐François, Imbert, Véronique

Volltext

NF-KB inhibition triggers death of imatinib-sensitive and imatinib-resistant chronic myeloid leukemia cells including T315I Bcr-Abl mutants von LOUNNAS, Nadia, FRELIN, Catherine, PEYRON, Jean-François, IMBERT, Véronique, GONTHIER, Nadège, COLOSETTI, Pascal, SIRVENT, Anne, CASSUTO, Jil-Patrice, BERTHIER, Fréderic, SIRVENT, Nicolas, ROUSSELOT, Philippe, DREANO, Michel

Volltext

Pharmacological Blockade of NF-kB Targets Both Imatinib-Sensitive or -Resistant Chronic Myeloid Leukemia Cells for Cell Death von Imbert, Véronique, Lounnas, Nadia, Frelin, Catherine, Gonthier, Nadège, Griessinger, Emmanuel, Sirvent, Nicolas, Hummelberger, Michael, Cassuto, Jil-Patrice, Mahon, François-Xavier, Michiels, Jean-François, Rousselot, Philippe, Dreano, Michel, Peyron, Jean-François

Volltext

NF-kappaB inhibition triggers death of imatinib-sensitive and imatinib-resistant chronic myeloid leukemia cells including T315I Bcr-Abl mutants von Lounnas, Nadia, Frelin, Catherine, Gonthier, Nadège, Colosetti, Pascal, Sirvent, Anne, Cassuto, Jil-Patrice, Berthier, Fréderic, Sirvent, Nicolas, Rousselot, Philippe, Dreano, Michel, Peyron, Jean-François, Imbert, Véronique

Volltext